Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_377d39cc83ba5b1d22d7ec93c971fe05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc10898deaadd5a1818f4e222280d872 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 |
filingDate |
2014-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7d2fe7682d85625ef9b811db83922f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c20780c18fc60670ef0ef9e8a4fbcd46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6900aad00f4837ca25063dcfbc478eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34a2f0cd92995cec5fdf2d56f1705e13 |
publicationDate |
2015-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2015140328-A |
titleOfInvention |
Silk fibroin aqueous solution and method for producing the same |
abstract |
PROBLEM TO BE SOLVED: To obtain an agent for transdermal absorption excellent in sustained release and transdermal absorbability. An agent for percutaneous absorption containing high molecular weight silk fibroin, a cyclic compound, and an active ingredient is used. Moreover, this agent for percutaneous absorption may further contain a guanidino group-containing compound. The cyclic compound may be a cyclic oligosaccharide or a cyclic compound for inclusion of an active ingredient. [Selection] Figure 7 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023190130-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021253881-A1 |
priorityDate |
2014-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |